pharmacy ethics

Summary

Summary: The principles of proper professional conduct concerning the rights and duties of the pharmacist, relations with patients and fellow practitioners, as well as actions of the pharmacist in health care and interpersonal relations with patient families. (From Stedman, 25th ed)

Top Publications

  1. ncbi "Death was a blessing"--should it ever be pharmaceutically hastened? British pharmacists' views
    Elizabeth A Hackett
    Pharmacy Department, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    Pharm World Sci 25:288-93. 2003
  2. ncbi Medication error reporting by community pharmacists in Vermont
    Amanda G Kennedy
    Division of General Internal Medicine, College of Medicine, University of Vermont, 371 Pearl Street, Burlington, VT 05401, USA
    J Am Pharm Assoc (2003) 44:434-8. 2004
  3. ncbi Conscientious objection and collaborative practice: conflicting or complementary initiatives?
    Susan C Winckler
    American Pharmacists Association, Washington, DC 20037 2985, USA
    J Am Pharm Assoc (2003) 46:12-3. 2006
  4. ncbi Conscientious objection: a pharmacist's right or professional negligence?
    Emily W Evans
    College of Pharmacy, University of Louisiana at Monroe, Shreveport, LA 71103, USA
    Am J Health Syst Pharm 64:139-41. 2007
  5. ncbi Blowing the whistle: a pharmacist's vexing experience unraveled
    Jeffrey Fudin
    Stratton Veterans Affairs Medical Center, Albany, NY 12054, USA
    Am J Health Syst Pharm 63:2262-5. 2006
  6. ncbi Moral courage through a collective voice
    Julie Aultman
    Northeastern Ohio Universities' College of Medicine, Kent, OH 44240, USA
    Am J Bioeth 8:67-9; author reply W3-4. 2008
  7. ncbi Medical pluralism in action? A case study of community pharmacies in Johannesburg, South Africa
    Leah Gilbert
    Department of Sociology, School of Social Sciences, University of the Witwatersrand, Johannesburg, South Africa
    J Altern Complement Med 10:547-55. 2004
  8. ncbi Pharmacists around the globe meet in New Orleans
    Cheryl A Thompson
    Am J Health Syst Pharm 61:2238-40. 2004
  9. ncbi The ethics of off-label use of drugs: oncology pharmacy in Italy
    A Bernardi
    Istituto Oncologico Veneto IRCCS, Padova, Italy
    J Clin Pharm Ther 33:95-9. 2008
  10. ncbi Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use
    Hannsjörg W Seyberth
    Philipps University, Marburg, Germany
    Pediatr Nephrol 20:1537-40. 2005

Research Grants

  1. Outpatient Prescription Errors
    AMANDA KENNEDY; Fiscal Year: 2007

Detail Information

Publications95

  1. ncbi "Death was a blessing"--should it ever be pharmaceutically hastened? British pharmacists' views
    Elizabeth A Hackett
    Pharmacy Department, St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, UK
    Pharm World Sci 25:288-93. 2003
    ..To investigate the views and experiences of British pharmacists in physician-assisted suicide (PAS) and voluntary active euthanasia (VAE) and to examine whether differences in views were associated with personal characteristics...
  2. ncbi Medication error reporting by community pharmacists in Vermont
    Amanda G Kennedy
    Division of General Internal Medicine, College of Medicine, University of Vermont, 371 Pearl Street, Burlington, VT 05401, USA
    J Am Pharm Assoc (2003) 44:434-8. 2004
    ..To document community pharmacists' awareness and use of the United States Pharmacopeia Medication Errors Reporting (USP MER) program...
  3. ncbi Conscientious objection and collaborative practice: conflicting or complementary initiatives?
    Susan C Winckler
    American Pharmacists Association, Washington, DC 20037 2985, USA
    J Am Pharm Assoc (2003) 46:12-3. 2006
  4. ncbi Conscientious objection: a pharmacist's right or professional negligence?
    Emily W Evans
    College of Pharmacy, University of Louisiana at Monroe, Shreveport, LA 71103, USA
    Am J Health Syst Pharm 64:139-41. 2007
  5. ncbi Blowing the whistle: a pharmacist's vexing experience unraveled
    Jeffrey Fudin
    Stratton Veterans Affairs Medical Center, Albany, NY 12054, USA
    Am J Health Syst Pharm 63:2262-5. 2006
  6. ncbi Moral courage through a collective voice
    Julie Aultman
    Northeastern Ohio Universities' College of Medicine, Kent, OH 44240, USA
    Am J Bioeth 8:67-9; author reply W3-4. 2008
  7. ncbi Medical pluralism in action? A case study of community pharmacies in Johannesburg, South Africa
    Leah Gilbert
    Department of Sociology, School of Social Sciences, University of the Witwatersrand, Johannesburg, South Africa
    J Altern Complement Med 10:547-55. 2004
    ..The main aim of this study was to examine whether, and to what extent, community pharmacies have become sites for the practice of complementary and alternative medicine (CAM) as an example of "medical pluralism."..
  8. ncbi Pharmacists around the globe meet in New Orleans
    Cheryl A Thompson
    Am J Health Syst Pharm 61:2238-40. 2004
  9. ncbi The ethics of off-label use of drugs: oncology pharmacy in Italy
    A Bernardi
    Istituto Oncologico Veneto IRCCS, Padova, Italy
    J Clin Pharm Ther 33:95-9. 2008
    ..The pharmacist has to maintain his/her professional integrity, and orient it towards accurate evaluation of the so-called 'circumstances of compromise in ethics'...
  10. ncbi Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use
    Hannsjörg W Seyberth
    Philipps University, Marburg, Germany
    Pediatr Nephrol 20:1537-40. 2005
  11. ncbi "We are white coats whirling round"--moral distress in Swedish pharmacies
    Sofia Kälvemark Sporrong
    Department of Public Health and Caring Sciences, Uppsala Science Park, 751 85, Uppsala, Sweden
    Pharm World Sci 27:223-9. 2005
    ..There are very few similar studies in pharmacy settings. This article reports on the results of an investigation concerning whether and in what situations moral distress is present in pharmacy practice...
  12. ncbi [Is the pharmaceutical industry really as bad as its reputation?]
    Enrique H Prat
    Imabe Institut für medizinische Anthropologie und Bioethik, Wien, Austria
    Wien Med Wochenschr 155:502-12. 2005
    ..People have to consume pharmaceutical products even though they do not like doing so, and therefore cannot be expected to champion the cause of the branch. It needs to adopt another strategy in order to improve its image...
  13. ncbi Evaluation of consultation in community pharmacies with mystery shoppers
    Dietrich Alte
    Institute of Epidemiology and Social Medicine, Ernst Moritz Arndt Universitat Greifswald, Greifswald, Germany
    Ann Pharmacother 41:1023-30. 2007
    ..Consultation of patients in community pharmacies (CPs) must meet standards, especially in selling over-the-counter drugs; however, there has been no information as to whether northeastern German CPs meet these standards...
  14. ncbi Two cheers for conscience exceptions
    Adrienne Asch
    Wurzweiler School of Social Work, USA
    Hastings Cent Rep 36:11-2. 2006
  15. ncbi Pharmacist-patient relationship development in an ambulatory clinic setting
    C J Hermansen
    Division of Social and Administrative Sciences, University of Wisconsin-Madison, School of Pharmacy, 53705-2222, USA
    Health Commun 13:307-25. 2001
    ..05). Findings suggested that patients' perceptions of their pharmacists, and not their therapy, may lead to increased interpersonal exchange and patient collaboration in care...
  16. ncbi Consistent standards in medication use: the need to care for patients from research to practice
    Christina L Cipolle
    College of Pharmacy, University of Minnesota, 308 Harvard Street S E, Minneapolis, MN 55455 0343, USA
    J Am Pharm Assoc (2003) 46:205-12. 2006
    ..To propose adoption of practice standards for pharmacists based on the principles of pharmaceutical care that are parallel to internationally accepted ethical precepts governing clinical research...
  17. ncbi Gene therapy: applications to pharmacy practice
    Robert I Roth
    The Weinberg Group, San Francisco, Calif 94105, USA
    J Am Pharm Assoc (Wash) 42:692, 694-8. 2002
  18. ncbi Future pharmacists have many questions to ponder
    Emily Stamos
    School of Pharmacy, University of Wisconsin-Madison, USA
    J Am Pharm Assoc (2003) 44:424, 426. 2004
  19. ncbi Re: Bioethics, the Surviving Sepsis Campaign, and the industry
    Georg Roggla
    Wien Klin Wochenschr 118:65. 2006
  20. ncbi Re: Bioethics, the Surviving Sepsis Campaign, and the industry
    Alasdair F Mackenzie
    Wien Klin Wochenschr 118:64. 2006
  21. ncbi [Medical ethics as output of economically motivated industrial objectives]
    U H Bode
    Vereinigung pharmazeutischer Unternehmen, Zieglergasse 5, A 1072 Wien
    Wien Med Wochenschr 152:309-12. 2002
    ..Possible ethical deficiencies arising from a lack of direct contact of the patient with industry and the quasi-penalisation of patients because of faulty lifestyle are briefly discussed...
  22. ncbi For debate: is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive?
    David Ames
    University of Melbourne, Australia
    Int Psychogeriatr 19:1003. 2007
  23. ncbi Unsolicited fluoxetine mailing triggers investigation in USA
    Marilynn Larkin
    Lancet 360:234. 2002
  24. ncbi Plea for better communication and interaction
    Terence J Ryan
    Wound Repair Regen 10:342. 2002
  25. ncbi [For and against: does sponsoring impede the growth of knowledge in medicine?]
    Asmus Finzen
    Psychiatr Prax 34:162-4. 2007
  26. ncbi Pharmaceutical companies and the third world
    Sanjay A Pai
    Lancet 361:1136-7. 2003
  27. ncbi Prescriber profiling
    Alexander C Tsai
    Ann Intern Med 148:81. 2008
  28. ncbi Pharmaceutical drug promotion: how it is being practiced in India?
    A Lal
    Clinical Pharmacology Unit, Department of Pharmacology, University College of Medical Sciences and GTB Hospital, Shahdara, Delhi 110 095, India
    J Assoc Physicians India 49:266-73. 2001
    ..Various medical and consumer groups should also intervene to improve the scenario of promotion...
  29. ncbi Prescriber profiling
    Adriane Fugh-Berman
    Ann Intern Med 148:82. 2008
  30. ncbi Prescriber profiling
    Stephen E Pratt
    Ann Intern Med 148:81-2. 2008
  31. ncbi Need to develop a legal and ethical base for pharmaceutical care. 1994
    Richard A Hutchinson
    Ann Pharmacother 41:1281-3. 2007
  32. ncbi Ethical, scientific, and educational concerns with unproven medications
    W Steven Pray
    College of Pharmacy, Southwestern Oklahoma State University, Weatherford, OK 73096, USA
    Am J Pharm Educ 70:141. 2006
    ..They must stress the value of evidence-based medicine and urge students and pharmacists to recommend only those medications with evidence-based proof of safety and efficacy...
  33. ncbi Prescriber profiling: time to call it quits
    David Grande
    Ann Intern Med 146:751-2. 2007
  34. ncbi Pharmaceutical marketing research and the prescribing physician
    Jeremy A Greene
    Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    Ann Intern Med 146:742-8. 2007
    ..Examination of the role of physicians and physician organizations in the development of prescriber profiling is directly relevant to the contemporary policy debate surrounding this issue...
  35. ncbi Efficacy and safety of pramipexole in restless legs syndrome
    Stefan P Kruszewski
    Neurology 68:1641; author reply 1641-2. 2007
  36. ncbi Doctors behaving badly?
    Martin H N Tattersall
    Med J Aust 185:299-300. 2006
  37. ncbi History of Pharmacy Museum of the Faculty of Pharmacy University of Belgrade
    Dusanka Krajnovic
    Faculty of Pharmacy, Institute for Social Pharmacy and Pharmaceutical Legislation, Belgrade, Serbia
    Acta Med Hist Adriat 7:179-90. 2009
    ....
  38. ncbi A new prescription for empirical ethics research in pharmacy: a critical review of the literature
    R J Cooper
    Centre for Pharmacy, Health and Society, The University of Nottingham, University Park, Nottingham NG7 2RD, UK
    J Med Ethics 33:82-6. 2007
    ..A descriptive and critical review of the extant empirical pharmacy ethics literature is provided here...
  39. ncbi Influence of attitudes toward curriculum on dishonest academic behavior
    Zubin Austin
    Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
    Am J Pharm Educ 70:50. 2006
    ....
  40. ncbi [What kind of ethical education for pharmacists is necessary? Can "the core curriculum model for pharmacology education" provide the needed guidance?]
    Jun Matsuda
    Shizuoka University, Faculty of Humanities and Social Sciences, Shizuoka, Japan
    Yakugaku Zasshi 129:807-13. 2009
    ..Humanism-based ethics are too narrow for pharmacy ethics. Pharmacy students should learn a more comprehensive ethics that covers social ethics, bioethics, and ..
  41. ncbi A comparative pilot study of the professional ethical thinking of Quebec pharmacy residents and French pharmacy interns
    Karin Scharr
    Unité de Recherche en Pratique Pharmaceutique, CHU Sainte Justine, Montreal, QC, Canada
    Int J Clin Pharm 33:974-84. 2011
    ..The secondary objective is to compare the professional ethical thinking of Quebec pharmacy residents and first year French pharmacy interns...
  42. ncbi What patients think about promotional activities of pharmaceutical companies in Turkey
    Semih Semin
    Department of Medical Ethics, Dokuz Eylul University, Medical Faculty Inciralti, Izmir, 35340, Turkey
    Pharm World Sci 28:199-206. 2006
    ..The goal of our study, therefore, is to investigate the patients' opinion on the promotional activities of pharmaceutical companies...
  43. ncbi The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials
    Gisela Schott
    Arzneimittelkommission der deutschen Arzteschaft, Berlin, Germany
    Dtsch Arztebl Int 107:279-85. 2010
    ..Moreover, pharmaceutical companies have been found to influence drug trials in various ways. This paper provides an overview of the findings of current, systematic studies on this topic...
  44. ncbi Healthcare professionals and the reciprocal duty to treat during a pandemic disaster
    Darren P Mareiniss
    Center for Health and Homeland Security, University of Maryland, 8106 Pampas Cove, Austin, TX 78750, USA
    Am J Bioeth 8:39-41. 2008
  45. ncbi Promotional literature: how do we critically appraise?
    V V Shetty
    Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Parel, Mumbai 400 012, India
    J Postgrad Med 54:217-21. 2008
    ..Critical appraisal of promotional literature can provide valuable information to the busy physician to practice evidence-based medicine...
  46. ncbi Ethical decision-making, passivity and pharmacy
    R J Cooper
    Division of Social Research in Medicines and Health, The University of Nottingham, University Park, Nottingham NG7 2RD, UK
    J Med Ethics 34:441-5. 2008
    ..A four-stage decision-making model involving ethical attention, reasoning, intention and action offers further insights into how more than reasoning alone may contribute to decision-making...
  47. ncbi The accuracy of psychiatric medication advertisements in medical journals
    Glen I Spielmans
    Department of Psychology, Metropolitan State University, St Paul, Minnesota 55108, USA
    J Nerv Ment Dis 196:267-73. 2008
    ..Given the relatively poor empirical substantiation of claims made in medical journal psychiatric drug advertisements and that most claims provided no attainable sources, increased regulation of such advertising is warranted...
  48. ncbi [Moral dilemmas of the pharmacist--ways of coping with ethical problems in light of case studies]
    Kazumi Kawamura
    Sugi Medical Co, Ltd, Tokyo, Japan
    Yakugaku Zasshi 129:793-806. 2009
    ..The need is urgent, therefore, for us to apply an understanding of ethical theory and conduct systematic case method-based ethical education to cultivate an ethical outlook among pharmacological students and pharmacists...
  49. ncbi Pharmacists and industry: guidelines for ethical interactions
    Randy C Hatton
    Ammerican College of Clinical Pharmacy, Lenexa, KS 66215, USA
    Pharmacotherapy 28:410-20. 2008
  50. ncbi Prescriber profiling
    Stephen M Kirk
    Ann Intern Med 148:82. 2008
  51. ncbi Undergraduate and postgraduate pharmacy students' perceptions of plagiarism and academic honesty
    Greg Ryan
    Faculty of Pharmacy, University of Sydney, Australia
    Am J Pharm Educ 73:105. 2009
    ..To assess undergraduate and postgraduate pharmacy students' perceptions of plagiarism and academic honesty...
  52. ncbi Healthcare without conscience--unconscionable!
    Gene Rudd
    Christian Medical and Dental Associations, 2604 Highway 421, PO Box 7500, Bristol, TN 37621, USA
    Ann Pharmacother 41:1903-5. 2007
    ..We can define better solutions for access to legal prescriptions and therapies without demanding that healthcare professionals become complicit in activities they deem immoral...
  53. ncbi Response to commentators on "Conscientious objection and emergency contraception": sex, drugs and the rocky role of levonorgestrel
    Robert F Card
    Am J Bioeth 7:4-6. 2007
  54. ncbi Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No
    Sarmishtha Bhattacharyya
    The University of Manchester, UK
    Int Psychogeriatr 19:1010-4; discussion 1014-20. 2007
  55. ncbi [Yes to research, no to utilization? Medical, pharmacological and toxicological utilization of human embryonic stem cells from an ethical point of view]
    H Kress
    Evang Theol Fakultät Abt Sozialethik, Universitat Bonn, Bonn, BRD
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51:965-72. 2008
    ..This follows from the basic human right to health protection and health care. Legal ambiguities, which still exist in this respect, should be removed...
  56. ncbi Yes, industry influence is excessive
    Amit A Shah
    Section of Geriatric Medicine, University of Texas-Southwestern, Dallas TX, USA
    Int Psychogeriatr 19:1004-10; discussion 1014-20. 2007
  57. ncbi Conscientious refusal by physicians and pharmacists: who is obligated to do what, and why?
    Dan W Brock
    Department of Social Medicine, Harvard Medical School, 651 Huntington Avenue, FXB Building, Rm 643, Boston, MA, 02115, USA
    Theor Med Bioeth 29:187-200. 2008
    ..Put together, this provides my answer to the question posed in the title of my paper: "Conscientious refusal by physicians and pharmacists: who is obligated to do what, and why?"...
  58. ncbi Ethics and the FDA
    John Fielder
    IEEE Eng Med Biol Mag 25:13-7. 2006
  59. ncbi Perceived importance of pharmacy management skills
    Richard J Faris
    Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee, Memphis, USA
    Am J Health Syst Pharm 62:1067-72. 2005
    ..CONCLUSION: Surveys in the United States and Canada found differences and similarities in pharmacy managers' opinions of the importance of managerial skills and in self-rated managerial strengths. Also identified were gaps in training...
  60. ncbi The Vioxx debacle
    John H Fielder
    IEEE Eng Med Biol Mag 24:106-9. 2005
  61. ncbi A resident's perspective on professionalism in pharmacy
    Kelly P Masters
    Shenandoah University, Winchester, VA 22601, USA
    Am J Health Syst Pharm 62:142-3. 2005
  62. ncbi Profile: Daniel Callahan
    Stephan Herrera
    Nat Biotechnol 22:1495. 2004
  63. ncbi Ethics in Christianity and health care: can "character" be defined in this interdisciplinary course?
    A E Broeseker
    Department of Pharmacy Practice, McWhorter School of Pharmacy, Samford University, Birmingham, AL 35229, USA
    Ann Pharmacother 33:489-94. 1999
    ..To describe a unique interdisciplinary ethics course that incorporates elements of character into a decision-making model...
  64. ncbi Conscience, the law, and donation of expired drugs
    Ene I Ette
    Ann Pharmacother 38:1310-3. 2004
  65. ncbi The Scope of pharmacy ethics-an evaluation of the international research literature, 1990-2002
    Joy Wingfield
    The Pharmacy School, University of Nottingham, Nottingham, NG7 2RD, England, UK
    Soc Sci Med 58:2383-96. 2004
    ..ethics in pharmacy practice and almost none addressing fundamental philosophical issues or values for pharmacy ethics. There is no dedicated journal for pharmacy ethics...
  66. ncbi Why withholding a prescription is unethical: a bioethical analysis of a far too familiar case
    Alex Cahana
    Department of Anesthesiology, Geneva University Hospital, Switzerland
    Pain Med 4:388-9. 2003
  67. ncbi Professionalism in pharmacy. Professionalism and the APhA House of Delegates
    Valerie T Prince
    McWhorter School of Pharmacy, Samford University, Birmingham, Ala, USA
    J Am Pharm Assoc (2003) 43:452-4. 2003
  68. ncbi [Prosecution of Mélanie Hahnemann in 1847 at the court of Paris: illegal practise of pharmacy and medicine]
    Francis Trépardoux
    Rev Hist Pharm (Paris) 50:427-38. 2002
    ..The court fined her for hundred francs that she paid. Then, she kept the circle of her friends and continued in medical counselling...
  69. ncbi Pharmacogenomics: ethical concerns for research and pharmacy practice
    M Gabriela Alcalde
    Institute for Bioethics, Health Policy, and Law, University of Louisville School of Medicine, 501 East Broadway, Suite 310, Louisville, KY 40292, USA
    Am J Health Syst Pharm 59:2239-40. 2002
  70. ncbi Trustworthiness and professional ethics
    Amy Haddad
    School of Pharmacy and Allied Health Professions, Creighton University, Omaha, Neb, USA
    J Am Pharm Assoc (Wash) 42:540-1. 2002
  71. ncbi The relationship between pharmacists' tenure in community setting and moral reasoning
    D A Latif
    Bernard J Dunn School of Pharmacy, Shenandoah University, Winchester, VA 22601, USA
    J Bus Ethics 31:131-41. 2001
    ....
  72. ncbi The ethics of post-marketing surveillance of therapeutic agents
    R G Beran
    Australian College of Legal Medicine, Strategic Health Evaluators, Chatswood, NSW
    Med Law 20:587-94. 2001
    ..This paper will explore such cases and discuss approaches to improve post marketing surveillance and patient protection...
  73. ncbi Ethical cognition and selection-socialization in retail pharmacy
    D A Latif
    Department of Biopharmaceutical Sciences, School of Pharmacy, 1460 University Drive, Winchester, VA 22601
    J Bus Ethics 25:343-57. 2000
    ..Implications for retail practice and limitations are discussed...
  74. ncbi Adoption of a pharmacist conscience clause by Professional Associations and Boards of Pharmacy in the United States
    H A Monsanto
    Department of Pharmacy Practice, School of Pharmacy, University of Puerto Rico, San Juan, Puerto Rico 00936 5067
    P R Health Sci J 18:401-4. 1999
    ..To determine the number of professional associations and boards of pharmacy in the United States that have adopted or are considering to adopt a conscience clause as part of their codes of ethics, rules, laws or regulations...
  75. ncbi Bioethics, the Surviving Sepsis Campaign, and the industry
    Christian J Wiedermann
    Department of Medicine, Central Hospital of Bolzano, Bolzano, Italy
    Wien Klin Wochenschr 117:442-4. 2005
  76. ncbi Pharmacists, pharmaceutical manufacturers, and conflicts of interest
    David Banks
    Office of Special Health Issues, Food and Drug Administration, Rockville, MD 20857, USA
    Am J Health Syst Pharm 62:1827-32. 2005
  77. ncbi Balancing pharmacists' conscientious objections with their duty to serve
    Charles D Hepler
    Department of Pharmacy Health Care Administration, College of Pharmacy, University of Florida, Gainesville, USA
    J Am Pharm Assoc (2003) 45:434-6. 2005
  78. ncbi Response to: Ethics, data and the pharmaceutical physician
    A D Dayan
    Int J Clin Pract 60:1009; author reply 1009. 2006
  79. ncbi Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan
    Dileep Kumar Rohra
    Department of Biological and Biomedical Sciences, The Aga Khan University, Karachi, Pakistan
    J Pharm Pharm Sci 9:50-9. 2006
    ..Objectives. To audit the drug promotional claims made by the pharmaceutical companies in Pakistan...
  80. ncbi Re: Bioethics, the Surviving Sepsis Campaign, and the industry
    Giovanni Ricevuti
    Wien Klin Wochenschr 118:64-5. 2006
  81. ncbi Re: Bioethics, the Surviving Sepsis Campaign, and the industry
    Alberto Malliani
    Wien Klin Wochenschr 118:63-4. 2006
  82. ncbi Curbside conversation about noblesse oblige and moral commitment
    Max D Ray
    College of Pharmacy, Western University of Health Sciences, 309 East Second Street, Pomona, CA 91766-1854, USA
    Am J Health Syst Pharm 63:666-9. 2006
  83. ncbi Pain, the DEA, and the impact on patients
    Will Rowe
    American Pain Foundation, Baltimore, MD, USA
    Pain Med 7:86. 2006
  84. ncbi Pain management misstatements: ceiling effects, red and yellow flags
    Steven D Passik
    Memorial Sloan Kettering Cancer Center
    Pain Med 7:76-7. 2006
  85. ncbi Future of emergency contraception lies in pharmacists' hands
    Nicole Monastersky
    Pharmacy Access Partnership, Public Health Institute, Oakland, CA, USA
    J Am Pharm Assoc (2003) 46:84-8. 2006
    ....
  86. ncbi New Mexico pharmacists' knowledge, attitudes, and beliefs toward prescribing oral emergency contraception
    Matthew E Borrego
    University of New Mexico Health Sciences Center, College of Pharmacy, Albuquerque 87131 1066, USA
    J Am Pharm Assoc (2003) 46:33-43. 2006
    ..To describe New Mexico pharmacists' knowledge, attitudes, and beliefs toward the prescribing of oral emergency contraception (EC) in their practices...
  87. ncbi [Message from the President at the National Academy of Pharmacy]
    Jacques Chirac
    Ann Pharm Fr 63:245. 2005
  88. ncbi Professionals, conformity, and conscience
    Rebecca Dresser
    Law School of Washington University, St. Louis, USA
    Hastings Cent Rep 35:9-10. 2005
  89. ncbi Dispensing with liberty: conscientious refusal and the "morning-after pill"
    Elizabeth Fenton
    Department of Philosophy, University of Virginia, Charlottesville, Virginia 22904, USA
    J Med Philos 30:579-92. 2005
    ..Asking "What is second best?" rather than "What is best?" offers a way to navigate the liberty restrictions that may be fixed obstacles to optimality...
  90. ncbi Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
    R Bickerstaffe
    Ethical Issues Committee, Faculty of Pharmaceutical Medicine, London, UK
    Int J Clin Pract 60:238-41. 2006
    ..These principles form the basis of a fuller report which offers more specific practical advice on possible ethical conflicts or dilemmas...
  91. ncbi Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK
    R Bickerstaffe
    Ethical Issues Committee, Faculty of Pharmaceutical Medicine, London, UK
    Int J Clin Pract 60:242-52. 2006
    ..It is hoped that the report will help those working in pharmaceutical medicine and act as a stimulus for wider discussion and debate...
  92. ncbi Bioethics, the Surviving Sepsis Campaign and the industry
    J Bion
    Wien Klin Wochenschr 118:63. 2006
  93. ncbi Relationship between selected personality traits and citation for violating pharmacy board regulations
    G Cocolas
    School of Pharmacy, University of North Carolina at Chapel Hill, 27599 7360, USA
    Am J Health Syst Pharm 57:456-60. 2000
    ..Significant differences in personality traits were found between pharmacists who had been cited for violating board of pharmacy regulations and general pharmacists and pharmacy leaders...
  94. ncbi Healthcare professionals and the DEA: trying to get back in balance
    Howard A Heit
    Georgetown University
    Pain Med 7:72-4. 2006
  95. ncbi The drug industry and clinical research in interwar America: three types of physician collaborator
    Nicolas Rasmussen
    School of History and Philosophy of Science, University of New South Wales, Sydney, NSW 2052, Australia
    Bull Hist Med 79:50-80. 2005
    ..These patterns may help illuminate the mutual accommodation between ethical drug firms and academic clinical researchers (and institutions) that still prevails today...

Research Grants1

  1. Outpatient Prescription Errors
    AMANDA KENNEDY; Fiscal Year: 2007
    ..Additionally, she will work closely with experienced investigators in the fields of Outcomes Research, Technology Assessment, and Human Factors Research. ..